These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Immunochemical studies on factor V. Greenquist AC; Weinberg RM; Kuo AL; Colman RW Eur J Biochem; 1975 Oct; 58(1):213-22. PubMed ID: 810349 [TBL] [Abstract][Full Text] [Related]
3. Heterogeneity of human factor V deficiency. Evidence for the existence of antigen-positive variants. Chiu HC; Whitaker E; Colman RW J Clin Invest; 1983 Aug; 72(2):493-503. PubMed ID: 6348091 [TBL] [Abstract][Full Text] [Related]
4. High-molecular-weight kininogen from horse plasma. Isolation, characterization and comparison with bovine high-Mr kininogen. Sugo T; Kato H; Iwanaga S; Fujii S Eur J Biochem; 1981 Apr; 115(3):439-47. PubMed ID: 6786881 [TBL] [Abstract][Full Text] [Related]
5. Molecular weight of undegraded plasma factor V. Mann KG; Nesheim ME; Tracy PB Biochemistry; 1981 Jan; 20(1):28-33. PubMed ID: 7470475 [TBL] [Abstract][Full Text] [Related]
6. Biosynthesis of factor V in isolated guinea pig megakaryocytes. Chiu HC; Schick PK; Colman RW J Clin Invest; 1985 Feb; 75(2):339-46. PubMed ID: 3973008 [TBL] [Abstract][Full Text] [Related]
7. Preparation and activity of factor V from small quantities of bovine plasma. White NB; Ferguson JH; Hitsumoto S Am J Med Sci; 1968 Feb; 255():143-51. PubMed ID: 5689081 [No Abstract] [Full Text] [Related]
8. Rat coagulation factor V purification and production of the monospecific antiserum. Cornillon B; Paul J; Mazzorana M; Belleville J Comp Biochem Physiol B; 1986; 83(2):397-401. PubMed ID: 3956160 [TBL] [Abstract][Full Text] [Related]
9. Studies on the stability of bovine plasma factor V. Day WC; Barton PG Biochim Biophys Acta; 1971 Feb; 261(2):457-68. PubMed ID: 5169152 [No Abstract] [Full Text] [Related]
10. Identification of a contaminant protein in the purification of human factor V. Comparison of two purification methods. Bruin T; Ockelford P; ten Cate JW; Sturk A; Breederveld C Biochim Biophys Acta; 1983 Oct; 748(1):139-42. PubMed ID: 6615848 [TBL] [Abstract][Full Text] [Related]
11. Characterization and experimental use of a monospecific antiserum to factor IX. Pechet L; Tiarks CY; Chang CH; Sudhindra RR; Lipworth L Thromb Haemost; 1979 Feb; 40(3):455-64. PubMed ID: 106483 [TBL] [Abstract][Full Text] [Related]
12. Purification and properties of the phenprocoumon-induced decarboxyfactor X from bovine plasma. A comparison to normal factor X. Lindhout MJ; Kop-Klaassen BH; Kop JM; Hemker HC Biochim Biophys Acta; 1978 Apr; 533(2):302-17. PubMed ID: 417733 [TBL] [Abstract][Full Text] [Related]
13. Characterization of guinea-pig high-molecular-weight kininogen as multi-functional molecule. Yamamoto T Biochim Biophys Acta; 1987 Aug; 914(3):259-74. PubMed ID: 3113483 [TBL] [Abstract][Full Text] [Related]
14. Purification and some properties of rabbit anti-ovalbumin. Ansari AA; Salahuddin A Biochem J; 1973 Dec; 135(4):705-11. PubMed ID: 4204953 [TBL] [Abstract][Full Text] [Related]
15. The size of human factor VIII heterodimers and the effects produced by thrombin. Fay PJ; Anderson MT; Chavin SI; Marder VJ Biochim Biophys Acta; 1986 Jun; 871(3):268-78. PubMed ID: 3085715 [TBL] [Abstract][Full Text] [Related]
19. Clinical significance of antibodies to bovine and human thrombin and factor V after surgical use of bovine thrombin. Rapaport SI; Zivelin A; Minow RA; Hunter CS; Donnelly K Am J Clin Pathol; 1992 Jan; 97(1):84-91. PubMed ID: 1728869 [TBL] [Abstract][Full Text] [Related]
20. A human neutrophil-dependent pathway for generation of angiotensin II: purification and physicochemical characterization of the plasma protein substrate. Wintroub BU; Klickstein LB; Kaempfer CE; Austen KF Proc Natl Acad Sci U S A; 1981 Feb; 78(2):1204-8. PubMed ID: 6785751 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]